Tom De Beule1, Thierry Boulanger1, Sam Heye1, Williem J van Rooij2, Wim van Zwam3, Luc Stockx1. 1. Department of Radiology, Ziekenhuis Oost-Limburg, Genk, Belgium. 2. Department of Radiology, Algemeen Ziekenhuis Turnhout, Turnhout, Belgium. 3. Department of Radiology, Maastricht Universiteit Medisch Centrum, Maastricht, the Netherlands.
Abstract
BACKGROUND AND PURPOSE: The Woven EndoBridge (WEB) is an intrasaccular flowdisruptor that is increasingly used for the treatment of (wide-necked) aneurysms. We present our experience with the WEB for unruptured aneurysms. MATERIALS AND METHODS: Between April 2014 and August 2019, 93 patients with 95 unruptured aneurysms were primarily treated with the WEB. There were 69 women and 24 men, mean age 61 years (median 58, range 37-80). RESULTS: Of 95 aneurysms, 86 had been discovered incidentally, 3 were symptomatic and 6 were additional to another ruptured aneurysm. Location was anterior communicating artery 33, middle cerebral artery 29, basilar tip 19, carotid tip 8, posterior communicating artery 4, posterior inferior cerebellar artery 1, superior cerebellar artery 1. Mean aneurysm size was 6 mm (median 6, range 3-13 mm).In one aneurysm additional coils were used and in another, a stent was placed. There was one procedural rupture without clinical sequelae. There were two thrombo-embolic complications leading to permanent deficit in one patient (mRS 2). Morbidity rate was 1.0% (1 of 93, 95%CI 0.01-6.5%) and mortality was 0% (0 of 93, 95%CI 0.0-4.8%). Angiographic follow-up at six months was available in 85 patients with 87 aneurysms (91%). Of 87 aneurysms, 68 (78%) were completely occluded, 14 (16%) had a neck remnant and 5 were incompletely occluded. Four aneurysms were retreated. Retreatment rate was 4.5% (4 of 87, 95%CI 1.7-13.6%). CONCLUSION: WEB treatment of unruptured aneurysms is safe and effective. Additional devices are needed only rarely and retreatment at follow-up is infrequent.
BACKGROUND AND PURPOSE: The Woven EndoBridge (WEB) is an intrasaccular flowdisruptor that is increasingly used for the treatment of (wide-necked) aneurysms. We present our experience with the WEB for unruptured aneurysms. MATERIALS AND METHODS: Between April 2014 and August 2019, 93 patients with 95 unruptured aneurysms were primarily treated with the WEB. There were 69 women and 24 men, mean age 61 years (median 58, range 37-80). RESULTS: Of 95 aneurysms, 86 had been discovered incidentally, 3 were symptomatic and 6 were additional to another ruptured aneurysm. Location was anterior communicating artery 33, middle cerebral artery 29, basilar tip 19, carotid tip 8, posterior communicating artery 4, posterior inferior cerebellar artery 1, superior cerebellar artery 1. Mean aneurysm size was 6 mm (median 6, range 3-13 mm).In one aneurysm additional coils were used and in another, a stent was placed. There was one procedural rupture without clinical sequelae. There were two thrombo-embolic complications leading to permanent deficit in one patient (mRS 2). Morbidity rate was 1.0% (1 of 93, 95%CI 0.01-6.5%) and mortality was 0% (0 of 93, 95%CI 0.0-4.8%). Angiographic follow-up at six months was available in 85 patients with 87 aneurysms (91%). Of 87 aneurysms, 68 (78%) were completely occluded, 14 (16%) had a neck remnant and 5 were incompletely occluded. Four aneurysms were retreated. Retreatment rate was 4.5% (4 of 87, 95%CI 1.7-13.6%). CONCLUSION: WEB treatment of unruptured aneurysms is safe and effective. Additional devices are needed only rarely and retreatment at follow-up is infrequent.
Authors: Pedro Lylyk; Jorge Chudyk; Carlos Bleise; Harald Sahl; Marta Aguilar Pérez; Hans Henkes; Pervinder Bhogal Journal: World Neurosurg Date: 2017-11-24 Impact factor: 2.104
Authors: Sbt van Rooij; M E Sprengers; J P Peluso; J Daams; D Verbaan; W J van Rooij; C B Majoie Journal: Interv Neuroradiol Date: 2020-02-06 Impact factor: 1.610
Authors: Laurent Pierot; Vincent Costalat; Jacques Moret; Istvan Szikora; Joachim Klisch; Denis Herbreteau; Markus Holtmannspötter; Werner Weber; Anne-Christine Januel; Thomas Liebig; Vojtech Sychra; Christoph Strasilla; Christophe Cognard; Alain Bonafé; Andrew Molyneux; James V Byrne; Laurent Spelle Journal: J Neurosurg Date: 2015-09-18 Impact factor: 5.115
Authors: R S Bechan; M E Sprengers; C B Majoie; J P Peluso; M Sluzewski; W J van Rooij Journal: AJNR Am J Neuroradiol Date: 2015-09-24 Impact factor: 3.825
Authors: S B T van Rooij; W J van Rooij; J P Peluso; M Sluzewski; R S Bechan; H G Kortman; G N Beute; B van der Pol; C B Majoie Journal: AJNR Am J Neuroradiol Date: 2017-09-07 Impact factor: 3.825
Authors: Annemijn M Algra; Antti Lindgren; Mervyn D I Vergouwen; Jacoba P Greving; Irene C van der Schaaf; Tristan P C van Doormaal; Gabriel J E Rinkel Journal: JAMA Neurol Date: 2019-03-01 Impact factor: 18.302
Authors: Pervinder Bhogal; Muhammad AlMatter; Victoria Hellstern; Oliver Ganslandt; Hansjörg Bäzner; Hans Henkes; Marta Aguilar-Pérez Journal: Neurointervention Date: 2018-03-02